The low dose of quetiapine did not alter baseline reward but completely blocked the effect of cocaine.
SS-RP partially blocked the effect of the hypercholesterolaemic agent, giving rise to a new balance of the antioxidant enzyme expression.
In agreement with a role for PACAP as a modulator, pre-administration of micromolar concentrations of PACAP completely blocked the effect of glutamate, whilst nanomolar concentrations induced per1 and per2 expression [84].
Honokiol stimulated LKB1 phosphorylation, and genetic deletion of LKB1 blocked the effect of honokiol on SREBP-1c maturation and the induction of SCD-1 and FAS proteins in FFA-exposed HepG2 cells.
Interestingly, pretreatment with AM251, a CB1 antagonist, blocked the effect of fluoxetine in FST and MBB at a dose (1 μg/mouse, i.c.v) that per se had no effect on either parameter.
Treatment of chondrocytes with cytochalasin D (an agent that disrupts the actin cytoskeleton) inhibited BMP 7-induced upregulation of tensin, talin, paxillin, and FAK, and blocked the effect of BMP 7 on chondrocyte phenotype.
The role of LOX-1 was further confirmed by the use of an antisense to LOX-1 mRNA, which also blocked the effect of ox-LDL in LDL-receptor expression.
AM251 blocked the effect of THC on body temperature.
In our experiments, methysergide selectively blocked the effect of serotonin on ciliary beat frequency.
Pretreatment with PTX blocked the effect of CHA on A2AR mRNA levels.
Application of THL blocked the effect of ghrelin (Fig. 2J L and Fig. 3A D).
